Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35394658

The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Hematol Oncol
Publication date
2022 Aug
First author
Shimazu Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Shimazu Y
      type
      Author
    2. name
      Murata M
      type
      Author
    3. name
      Kondo T
      type
      Author
    4. name
      Minami Y
      type
      Author
    5. name
      Tachibana T
      type
      Author
    6. name
      Doki N
      type
      Author
    7. name
      Uchida N
      type
      Author
    8. name
      Ozawa Y
      type
      Author
    9. name
      Yano S
      type
      Author
    10. name
      Fukuda T
      type
      Author
    11. name
      Kato J
      type
      Author
    12. name
      Ara T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Shimazu Y
      type
      Author
    2. name
      Murata M
      type
      Author
    3. name
      Kondo T
      type
      Author
    4. name
      Minami Y
      type
      Author
    5. name
      Tachibana T
      type
      Author
    6. name
      Doki N
      type
      Author
    7. name
      Uchida N
      type
      Author
    8. name
      Ozawa Y
      type
      Author
    9. name
      Yano S
      type
      Author
    10. name
      Fukuda T
      type
      Author
    11. name
      Kato J
      type
      Author
    12. name
      Ara T
      type
      Author
    bibliography ids
    1. nci-bib-d3f88903e6830d780be7d0f3
    book metadata
    content sha256
    e109e436a1c2e33fb51c86568c78461ea38c4a6b0a426fae361a33eb62ae56e4
    document type
    citation
    dois
    1. 10.1002/hon.3000
    electronic publication date
    display
    2022 Apr 12
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35394658
    immutable id
    pubmed:35394658@e109e436a1c2e33fb51c86568c78461ea38c4a6b0a426fae361a33eb62ae56e4
    journal
    abbreviation
    Hematol Oncol
    issn electronic
    1099-1069
    issn print
    0278-0232
    issue
    3
    name
    Hematological oncology
    nlm unique id
    8307268
    pages
    442-456
    volume
    40
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35394658
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      9e4bfd44bd6beef925832973cb4090e16180680e909d1f26e596c94992e5eb5e
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Aug
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Observational Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35394658/
      title
      The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.

      Preserved source evidence · Not medical advice